Phase 3 Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older.
- People with advanced chronic kidney disease (a kidney function level below a certain threshold, measured by a blood test) who are not currently on dialysis.
Who may not be able to join:
- People diagnosed with a genetic kidney condition called autosomal dominant polycystic kidney disease (ADPKD), which causes cysts to grow on the kidneys.
- People with Type 1 diabetes.
- People currently taking a type of medication known as SGLT2 inhibitors (a class of tablets sometimes used for diabetes or kidney disease).
- People who have had a serious condition called ketoacidosis (a dangerous build-up of acids in the blood) within the last 3 months.
- People with a known allergic reaction or sensitivity to SGLT2 inhibitor medications.
- People with known liver problems or liver disease.
- People who are pregnant or breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in the eGFR slope; Time to start of renal replacement therapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.